Scott Rocklage earned his PhD in chemistry at MIT working in the Nobel Prize-winning Richard Schrock laboratory before building an unusual operator-to-investor profile by serving as Chairman and CEO of Cubist Pharmaceuticals and President/CEO of Nycomed Salutar. He maintains an unusually broad global board footprint across biotech companies in the US, Europe, and Asia, and is known for actively partnering with technical founders to shape their ideas into potential medicines rather than taking a purely financial role. Scott Rocklage earned his PhD in chemistry at MIT working in the Nobel Prize-winning Richard Schrock laboratory before building an unusual operator-to-investor profile by serving as Chairman and CEO of Cubist Pharmaceuticals and President/CEO of Nycomed Salutar. He maintains an unusually broad global board footprint across biotech companies in the US, Europe, and Asia, and is known for actively partnering with technical founders to shape their ideas into potential medicines rather than taking a purely financial role.